Experiments on a lab scale TES unit using eutectic metal alloy as PCM

The behavior of a magnesium and zinc eutectic metal alloy used as thermal energy storage (TES) material is tested in a laboratory scale TES unit. The TES unit consists of two concentric tubes with the central tube surrounded by 67 kg of the metal alloy and two caps at both ends of the tube through which the heat transfer fluid (HTF) flows. Charging (melting) and discharging (solidification) processes of the eutectic metal alloy are performed using synthetic oil as the HTF. The experimental results are used to test the validity of the model via simulations performed with a computational fluid dynamics tool. The results corroborate that phase change materials with high thermal conductivity, such as eutectic metal alloys, are ideal for the evaporation process of water in direct steam generation applications due to the quasi-constant melting and solidification temperatures and to its high heat transfer capacityThe authors would like to thank the Department of Industry, Innovation, Commerce and Tourism of the Basque Government for funding Etortek 2011 Energigune’11 grant (IE11-303). The authors would like to express their gratitude to Felix Mendia for his valuable and constructive suggestions and very much appreciate the collaboration of Julian Izaga from IK4-Azterlan and Rafael de Diego from Melfun in the synthesis of the eutectic allo

Design of a 100 kW Concentrated Solar Power on Demand Volumetric Receiver With Integral Thermal Energy Storage Prototype

A new concept of Thermal Energy Storage (TES) system based on current available technologies is being developed under the framework of the Masdar Institute (MI) and Massachusetts Institute of Technology (MIT) collaborative Flagship Program. The key feature of this concept lies on concentrating sun light directly on the molten salt storage tank, avoiding the necessity of pumping the salts to the top of a tower thereby avoiding thermal losses and pumping and electric tracing needs inherent in most conventional CSP plants. This Concentrated Solar Power on Demand (CSPonD) volumetric receiver/TES unit prototype will be tested in the existing MI heliostat field and beam down tower in Abu Dhabi (UAE) which will collect and redirect solar energy to an upwards-facing final optical element (FOE). These energy will be concentrated on the aperture of the prototype designed to store 400 kWh of energy allowing 16 hours of continuous production after sunset using Solar Salt (60%NaNO3 + 40%KNO3) as storage material. The tank is divided in two volumes: one cold in the bottom region, where Solar Salt is at 250 °C and another hot on the upper region, at 550 °C. A moving divider plate with active control separates both volumes. The plate includes mixing enhancement features to help with convection on the hot volume of salts. It’s expected that results will demonstrate the technical feasibility and economic viability of this concept allowing its scale up at commercial size

Initiation and Single Dispensing in Cardiovascular and Insulin Medications: Prevalence and Explanatory Factors

: Background: Adherence problems have negative effects on health, but there is little information on the magnitude of non-initiation and single dispensing. Objective: The aim of this study was to estimate the prevalence of non-initiation and single dispensation and identify associated predictive factors for the main treatments prescribed in Primary Care (PC) for cardiovascular disease (CVD) and diabetes. Methods: Cohort study with real-world data. Patients who received a first prescription (2013-2014) for insulins, platelet aggregation inhibitors, angiotensin-converting enzyme inhibitors (ACEI) or statins in Catalan PC were included. The prevalence of non-initiation and single dispensation was calculated. Factors that explained these behaviours were explored. Results: At three months, between 5.7% (ACEI) and 9.1% (antiplatelets) of patients did not initiate their treatment and between 10.6% (statins) and 18.4% (ACEI) filled a single prescription. Body mass index, previous CVD, place of origin and having a substitute prescriber, among others, influenced the risk of non-initiation and single dispensation. Conclusions: The prevalence of non-initiation and single dispensation of CVD medications and insulin prescribed in PC in is high. Patient and health-system factors, such as place of origin and type of prescriber, should be taken into consideration when prescribing new medications for CVD and diabetes

New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population

Guidelines recommend routine screening for colorectal cancer (CRC) in asymptomatic adults starting at age 50. The most extensively used noninvasive test for CRC screening is the fecal immunochemical test (FIT), which has an overall sensitivity for CRC of approximately 61.0%-91.0%, which drops to 27.0%-67.0% for advanced adenomas. These figures contain a high false-positive rate and a low positive predictive value. This work aimed to develop a new, noninvasive CRC screening tool based on fecal bacterial markers capable of decreasing FIT false-positive rates in a FIT-positive population. We defined a fecal bacterial signature (RAID-CRC Screen) in a proof-of-concept with 172 FIT-positive individuals and validated the obtained results on an external cohort of 327 FIT-positive subjects. All study participants had joined the national CRC screening program. In the clinical validation of RAID-CRC Screen, a sensitivity of 83.9% and a specificity of 16.3% were obtained for the detection of advanced neoplasm lesions (advanced adenomas and/or CRC). FIT 20 μg/g produced 184 false-positive results. Using RAID-CRC Screen, this value was reduced to 154, thus reducing the false-positive rate by 16.3%. The RAID-CRC Screen test could be implemented in CRC screening programs to allow a significant reduction in the number of colonoscopies performed unnecessarily for FIT-positive participants of CRC screening programs

Preliminary Optical, Thermal and Structural Design of a 100 kWth CSPonD Beam-down On-sun Demonstration Plant

An innovative concept in which a single-tank molten salt thermal energy storage arrangement also acts as a volumetric receiver is being developed in connection with the CSPonD[superscript 2] (Concentrated Solar Power on Demand Demonstration) project. The tank is located at the focal point of a beam-down tower to act as both solar energy receiver and thermal energy storage. The relatively small angle subtended by rays emanating from the central reflector of a beam down optical system, together with the nature of solar energy absorption within the volumetric receiver, make use of a compound parabolic concentrator (CPC) or CPC-like final optical element attractive. An effective concentration of about 4 can be achieved to increase solar flux at the tank aperture from 150 to 600 suns. This paper describes preliminary designs of the CPC and tank/receiver. Optical simulations reveal that, for a given solar incident power at the tank aperture, a conical final concentrator design produces a more uniform flux distribution with better axial alignment (lower average horizontal component) of rays at its outlet compared to a conventional CPC of revolution. However the cone may require a larger outlet radius, leading to higher thermal losses through the tank aperture. With the current design of the tank, the losses through the walls correspond to 5.5 % of the thermal capacity. To maximize the tank thermal efficiency, a thorough investigation will be carried out, starting with measurements of the molten salt emissivity, to determine the cone outlet radius/tank aperture and cone height that achieve maximum system efficiency with a 250-550 °C molten salt working temperature range. Keywords: Thermal energy storage; Concentrated solar power; Molten salt; Thermocline; Beam-down tower; CPC, Cone, Ray-tracing.Abu Dhabi (United Arab Emirates)MIT & Masdar Institute Cooperative Progra

Initial medication non-adherence: prevalence and predictive factors in a cohort of 1.6 million primary care patients.

Adherence to medicines is vital in treating diseases. Initial medication non-adherence (IMNA) - defined as not obtaining a medication the first time it is prescribed - has been poorly explored. Previous studies show IMNA rates between 6 and 28% in primary care (PC). The aims of this study were to determine prevalence and predictive factors of IMNA in the most prescribed and expensive pharmacotherapeutic groups in the Catalan health system. This is a retrospective, register-based cohort study which linked the Catalan PC System (Spain) prescription and invoicing databases. Medication was considered non-initiated when it was not collected from the pharmacy by the end of the month following the one in which it was prescribed. IMNA prevalence was calculated using July 2013-June 2014 prescription data. Predictive factors related to patients, general practitioners and PC centres were identified through multilevel logistic regression analyses. Missing data were attributed using simple imputation. Some 1.6 million patients with 2.9 million prescriptions were included in the study sample. Total IMNA prevalence was 17.6% of prescriptions. The highest IMNA rate was observed in anilides (22.6%) and the lowest in angiotensin-converting-enzyme (ACE) inhibitors (7.4%). Predictors of IMNA are younger age, American nationality, having a pain-related or mental disorder and being treated by a substitute/resident general practitioner in a resident-training centre. The rate of IMNA is high when all medications are taken into account. Attempts to strengthen trust in resident general practitioners and improve motivation to initiate a needed medication in the general young and older immigrant population should be addressed in Catalan PC

Initiation and Single Dispensing in Cardiovascular and Insulin Medications: Prevalence and Explanatory Factors

Background: Adherence problems have negative effects on health, but there is little information on the magnitude of non-initiation and single dispensing. Objective: The aim of this study was to estimate the prevalence of non-initiation and single dispensation and identify associated predictive factors for the main treatments prescribed in Primary Care (PC) for cardiovascular disease (CVD) and diabetes. Methods: Cohort study with real-world data. Patients who received a first prescription (2013–2014) for insulins, platelet aggregation inhibitors, angiotensin-converting enzyme inhibitors (ACEI) or statins in Catalan PC were included. The prevalence of non-initiation and single dispensation was calculated. Factors that explained these behaviours were explored. Results: At three months, between 5.7% (ACEI) and 9.1% (antiplatelets) of patients did not initiate their treatment and between 10.6% (statins) and 18.4% (ACEI) filled a single prescription. Body mass index, previous CVD, place of origin and having a substitute prescriber, among others, influenced the risk of non-initiation and single dispensation. Conclusions: The prevalence of non-initiation and single dispensation of CVD medications and insulin prescribed in PC in is high. Patient and health-system factors, such as place of origin and type of prescriber, should be taken into consideration when prescribing new medications for CVD and diabetes

First and second waves of coronavirus disease-19: A comparative study in hospitalized patients in Reus, Spain.

Many countries have seen a two-wave pattern in reported cases of coronavirus disease-19 during the 2020 pandemic, with a first wave during spring followed by the current second wave in late summer and autumn. Empirical data show that the characteristics of the effects of the virus do vary between the two periods. Differences in age range and severity of the disease have been reported, although the comparative characteristics of the two waves still remain largely unknown. Those characteristics are compared in this study using data from two equal periods of 3 and a half months. The first period, between 15th March and 30th June, corresponding to the entire first wave, and the second, between 1st July and 15th October, corresponding to part of the second wave, still present at the time of writing this article. Two hundred and four patients were hospitalized during the first period, and 264 during the second period. Patients in the second wave were younger and the duration of hospitalization and case fatality rate were lower than those in the first wave. In the second wave, there were more children, and pregnant and post-partum women. The most frequent signs and symptoms in both waves were fever, dyspnea, pneumonia, and cough, and the most relevant comorbidities were cardiovascular diseases, type 2 diabetes mellitus, and chronic neurological diseases. Patients from the second wave more frequently presented renal and gastrointestinal symptoms, were more often treated with non-invasive mechanical ventilation and corticoids, and less often with invasive mechanical ventilation, conventional oxygen therapy and anticoagulants. Several differences in mortality risk factors were also observed. These results might help to understand the characteristics of the second wave and the behaviour and danger of SARS-CoV-2 in the Mediterranean area and in Western Europe. Further studies are needed to confirm our findings